Consider New Nuplazid for Some Patients With Parkinson's Psychosis

August 2016

The new antipsychotic, Nuplazid (new-PLAH-zid, pimavanserin), will raise questions about treating psychotic symptoms in Parkinson's patients.

Psychosis is common in Parkinson's...partly because the meds used to improve tremors and stiffness may cause hallucinations and delusions.

But antipsychotics block dopamine and can worsen motor function.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Vaccines Do Not Use the Intranasal Flu Vaccine This Year
Diabetes Consider Cardiovascular Benefits When Choosing Metformin Add-ons
Diabetes Monitor Kidney Function in Patients Starting an SGLT2 Inhibitor
Naloxone Help Clear Up Misconceptions about Naloxone
Gastroenterology Recommend Antacids WithOUT Aspirin for Patients at Risk for GI Bleeding
Migraine Use Another Form of Sumatriptan for Zecuity Patients
Parkinson's Disease Consider New Nuplazid for Some Patients With Parkinson's Psychosis
Enteral Tubes Start with Tap Water to Unclog Feeding Tubes
MRSA Help Patients Limit the Spread of MRSA in their Home
Opioids Consider Probuphine for Stable Patients on Low Dose Buprenorphine
Women's Health Be Familiar With Alternatives to Lyrica in Pregnant Women